-
JD Home Rapid Testing "12 Joint Tests for Respiratory Viruses and Bacteria" covering 10 cities nationwide
This year, there is a high incidence of respiratory diseases, and multiple pathogens such as influenza A, influenza B, Mycoplasma pneumoniae, and respiratory syncytial virus are simultaneously preval ... -
AstraZeneca: Leweichu has been approved in China for the prevention of respiratory syncytial virus infection in infants
AstraZeneca: Leweichu has been approved in China for the prevention of respiratory syncytial virus infection in infants. AstraZeneca and Sanofi jointly announced on January 2 that the long-acting mon ... -
AstraZeneca and Sanofi have been approved in China for the prevention of respiratory syncytial virus infection in infants with nisetizumab
On January 2nd, AstraZeneca and Sanofi jointly announced the long-acting monoclonal antibody Le Weichu& Reg; Nirsevimab has been officially approved for marketing by the National Medical Products Adm ... -
The first preventive measure against respiratory syncytial virus in all infants, Le Weichu? Approved in China
On January 2nd, AstraZeneca and Sanofi jointly announced the release of the long-acting monoclonal antibody Le Weichu& Reg; (Nisetivir monoclonal antibody) has officially been approved for marketing ... -
Modna mRNA respiratory syncytial virus vaccine approved for market in the European Union
On August 23rd local time, Moderna, a US biopharmaceutical company, announced that the European Commission (EC) has approved the mRNA respiratory syncytial virus (RSV) vaccine mRESVIA& reg; (mRNA-134 ...